Hyaluronic acid binding protein 2 Is a novel regulator of vascular integrity

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 30, Issue 3, 2010, Pages 483-490

  Mambetsariev, Nurbek ^a   Mirzapoiazova, Tamara ^a   Mambetsariev, Bolot ^a   Sammani, Saad ^a   Lennon, Frances E ^a   Garcia, Joe G N ^a   Singleton, Patrick A ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Endothelial barrier function; HABP2; Hyaluronan; Protease activated receptor; Vascular permeability

Indexed keywords

HYALURONIC ACID; HYALURONIC ACID BINDING PROTEIN; HYALURONIC ACID BINDING PROTEIN 2; LIPOPOLYSACCHARIDE; POLYANION; PROTEINASE ACTIVATED RECEPTOR 1; PROTEINASE ACTIVATED RECEPTOR 3; PROTEINASE ACTIVATED RECEPTOR 4; RHO KINASE; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; SERINE PROTEINASE; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ACUTE LUNG INJURY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BLOOD VESSEL PERMEABILITY; BLOOD VESSEL TONE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LUNG ENDOTHELIUM; MALE; MICROVASCULATURE; MOLECULAR WEIGHT; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SYNDROME; VENTILATOR;

ACUTE LUNG INJURY; ANIMALS; CELL MEMBRANE PERMEABILITY; DISEASE MODELS, ANIMAL; ENDOTHELIUM, VASCULAR; HUMANS; HYALURONIC ACID; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, INBRED C57BL; RECEPTORS, PROTEINASE-ACTIVATED; RHO-ASSOCIATED KINASES; RHOA GTP-BINDING PROTEIN; SERINE ENDOPEPTIDASES; SIGNAL TRANSDUCTION; VENTILATORS, MECHANICAL;

EID: 77649084110     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/ATVBAHA.109.200451     Document Type: Article

References (29)

1. Luscher TF, Barton M. Biology of the endothelium. Clin Cardiol. 1997; 20:II-3-II-10.
2. Singleton PA, Dudek SM, Ma SF, Garcia JG. Transactivation of sphin-gosine 1-phosphate receptors is essential for vascular barrier regulation: novel role for hyaluronan and CD44 receptor family. J Biol Chem. 2006;281:34381-34393.
3. Singleton PA, Salgia R, Moreno-Vinasco L, Moitra J, Sammani S, Mir-zapoiazova T, Garcia JG. CD44 regulates hepatocyte growth factor-mediated vascular integrity: role of c-Met, Tiam1/Rac1, dynamin 2, and cortactin. J Biol Chem. 2007;282:30643-30657.
4. Kanse SM, Parahuleva M, Muhl L, Kemkes-Matthes B, Sedding D, Preissner KT. Factor VII-activating protease (FSAP): vascular functions and role in atherosclerosis. Thromb Haemost. 2008;99:286-289.
5. Choi-Miura NH, Tobe T, Sumiya J, Nakano Y, Sano Y, Mazda T, Tomita M. Purification and characterization of a novel hyaluronan-binding protein (PHBP) from human plasma: it has three EGF, a kringle and a serine protease domain, similar to hepatocyte growth factor activator. J Biochem (Tokyo). 1996;119:1157-1165.
6. Romisch J. Factor VII activating protease (FSAP): a novel protease in hemostasis. Biol Chem. 2002;383:1119-1124.
7. Sidelmann JJ, Vitzthum F, Funding E, Munster AM, Gram J, Jespersen J. Factor VII-activating protease in patients with acute deep venous thrombosis. Thromb Res. 2008;122:848-853.
8. Kannemeier C, Feussner A, Stohr HA, Weisse J, Preissner KT, Romisch J. Factor VII and single-chain plasminogen activator-activating protease: activation and autoactivation of the proenzyme. Eur J Biochem. 2001;268: 3789-3796. (Pubitemid 32862919)
9. Altincicek B, Shibamiya A, Trusheim H, Tzima E, Niepmann M, Linder D, Preissner KT, Kanse SM. A positively charged cluster in the epidermal growth factor-like domain of factor VII-activating protease (FSAP) is essential for polyanion binding. Biochem J. 2006;394:687-692.
10. Nakazawa F, Kannemeier C, Shibamiya A, Song Y, Tzima E, Schubert U, Koyama T, Niepmann M, Trusheim H, Engelmann B, Preissner KT. Extracellular RNA is a natural cofactor for the (auto-)activation of factor VII-activating protease (FSAP). Biochem J. 2005;385:831-838.
11. Wygrecka M, Morty RE, Markart P, Kanse SM, Andreasen PA, Wind T, Guenther A, Preissner KT. Plasminogen activator inhibitor-1 is an inhibitor of factor VII-activating protease in patients with acute respiratory distress syndrome. J Biol Chem. 2007;282:21671-21682. (Pubitemid 47195746)
12. McClintock D, Zhuo H, Wickersham N, Matthay MA, Ware LB. Biomarkers of inflammation, coagulation and fibrinolysis predict mortality in acute lung injury. Crit Care. 2008;12:R41.
13. Wygrecka M, Markart P, Fink L, Guenther A, Preissner KT. Elevated protein levels and altered cellular expression of factor VII-activating protease (FSAP) in the lungs of patients with acute respiratory distress syndrome (ARDS). Thorax. 2007.
14. Garcia JG, Liu F, Verin AD, Birukova A, Dechert MA, Gerthoffer WT, Bamberg JR, English D. Sphingosine 1-phosphate promotes endothelial cell barrier integrity by Edg-dependent cytoskeletal rearrangement. J Clin Invest. 2001;108:689-701.
15. Ren XD, Kiosses WB, Schwartz MA. Regulation of the small GTP-binding protein Rho by cell adhesion and the cytoskeleton. EMBO J. 1999;18:578-585.
16. Su X, Wang L, Song Y, Bai C. Inhibition of inflammatory responses by ambroxol, a mucolytic agent, in a murine model of acute lung injury induced by lipopolysaccharide [published online ahead of print September 20, 2003]. Intensive Care Med. 2004;30:133-140.
17. Barnes JA, Singh S, Gomes AV. Protease activated receptors in cardiovascular function and disease. Mol Cell Biochem. 2004;263:227-239.
18. Ossovskaya VS, Bunnett NW. Protease-activated receptors: contribution to physiology and disease. Physiol Rev. 2004;84:579-621.
19. Gavard J, Gutkind JS. Protein kinase C-related kinase and ROCK are required for thrombin-induced endothelial cell permeability downstream from Galpha12/13 and Galpha11/q. J Biol Chem. 2008;283:29888-29896.
20. McLaughlin JN, Patterson MM, Malik AB. Protease-activated receptor-3 (PAR3) regulates PAR1 signaling by receptor dimerization. Proc Natl Acad Sci USA. 2007;104:5662-5667.
21. Vajda S, Bartha K, Wilhelm I, Krizbai IA, Adam-Vizi V. Identification of protease-activated receptor-4 (PAR-4) in puromycin-purified brain capillary endothelial cells cultured on Matrigel. Neurochem Int. 2008;52:1234-1239.
22. Muhl L, Galuska SP, Oorni K, Hernandez-Ruiz L, Andrei-Selmer LC, Geyer R, Preissner KT, Ruiz FA, Kovanen PT, Kanse SM. High negative charge-to-size ratio in polyphosphates and heparin regulates factor VII-activating protease. FEBS J. 2009;276:4828-4839.
23. van der Poll T. Tissue factor as an initiator of coagulation and inflammation in the lung. Crit Care. 2008;12(suppl 6):S3.
24. Wygrecka M, Markart P, Fink L, Guenther A, Preissner KT. Raised protein levels and altered cellular expression of factor VII activating protease (FSAP) in the lungs of patients with acute respiratory distress syndrome (ARDS). Thorax. 2007;62:880-888.
25. Wang KK, Liu N, Radulovich N, Wigle DA, Johnston MR, Shepherd FA, Minden MD, Tsao MS. Novel candidate tumor marker genes for lung adenocarcinoma. Oncogene. 2002;21:7598-7604.
26. Ireland H, Miller GJ, Webb KE, Cooper JA, Humphries SE. The factor VII activating protease G511E (Marburg) variant and cardiovascular risk. Thromb Haemost. 2004;92:986-992.
27. Hoppe B, Tolou F, Dorner T, Kiesewetter H, Salama A. Gene polymorphisms implicated in influencing susceptibility to venous and arterial thromboembolism: frequency distribution in a healthy German population. Thromb Haemost. 2006;96:465-470.
28. Sedding D, Daniel JM, Muhl L, Hersemeyer K, Brunsch H, Kemkes-Matthes B, Braun-Dullaeus RC, Tillmanns H, Weimer T, Preissner KT, Kanse SM. The G534E polymorphism of the gene encoding the factor VII-activating protease is associated with cardiovascular risk due to increased neointima formation. J Exp Med. 2006;203:2801-2807.
29. Ware LB, Matthay MA, Parsons PE, Thompson BT, Januzzi JL, Eisner MD. Pathogenetic and prognostic significance of altered coagulation and fibrinolysis in acute lung injury/acute respiratory distress syndrome. Crit Care Med. 2007;35:1821-1828.